-
Mechanism Exploration of Dunyeguanxinning in the Treatment of Atherosclerosis Based on UPLC-Q-Orbitrap HRMS Technology, Network Pharmacology, Molecular Docking and Experimental Validation
08 Apr 2025 15:04 GMT
… anti-AS drugs to broaden clinical treatment options.
In … purchased from Shanghai Tauto Biotech Co., Ltd. … The rosuvastatin group received rosuvastatin (cat# 132756, AstraZeneca Pharmaceuticals (China) … J, Czuczwar SJ. Statin-induced myopathies. Pharmacol Rep …
-
Combining Experimental Validation and Network Pharmacology to Reveal the Action Mechanism of Panax Notoginseng-Radix Salviae on Atherosclerosis
09 Apr 2025 13:09 GMT
… Drug Preparation
PN and RS were manufactured by Beijing Kangrentang Pharmaceutical … BCA) kit (Dalian Meilun Biotechnology Co., Ltd., Dalian, … to that of rosuvastatin treatment. These results suggested … PN-RS drugs on AS treatment, the drug treatment groups …
-
AstraZeneca’s AZD0780, a novel oral PCSK9 inhibitor, demonstrates significant LDL cholesterol reduction in PURSUIT phase IIb trial
02 Apr 2025 06:34 GMT
… of whether trial participants received moderate- or high-intensity statin doses at … -C levels on top of rosuvastatin treatment, with 80% total reduction from … , development, and commercialisation of prescription medicines in oncology, rare diseases, and …
-
Novel PCSK9 Inhibitor Achieves Significant Reduction in LDL Cholesterol Levels in Phase IIb Trial
01 Apr 2025 21:58 GMT
… trial principal investigator Michael J Koren, MD, CEO and medical … levels in addition to rosuvastatin treatment, translating to a total … well-tolerated, daily pill that could reliably lower … moderate- or high-intensity statins.
Investigators randomly assigned …
-
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial
31 Mar 2025 16:14 GMT
… of whether trial participants received moderate- or high- intensity statin doses at … -C levels on top of rosuvastatin treatment, with 80% total reduction from … , development and commercialization of prescription medicines in Oncology, Rare Diseases and …
-
Liver cancer combatted by statin use, study reveals
28 Mar 2025 08:17 GMT
… from Harvard Medical School have discovered that using statins protected adults … statins have antioxidant, antifibrotic and anti-inflammatory effects.
During the trial … by 36%.
Meanwhile, hydrophilic statins such as rosuvastatin and pravastatin reduced HCC …
-
Medicines Commission has authorized 24 medicines, including 13 new ones
27 Mar 2025 16:01 GMT
… Agency for Medicines and Medical Devices (AMDM) has authorized 24 medicinal products, … , among the newly authorized drugs are Bendamustine, prescribed to … pharmaceuticals such as Hydrocortisone, to suppress inflammatory or immune reactions, and Rosuvastatin …
-
Medicare $2 Drug List Model Could Have Reduced 2021 Out-of-Pocket Generic Costs
24 Mar 2025 21:51 GMT
… have been generated by 5 drugs: albuterol, metoprolol, levothyroxine, atorvastatin, and rosuvastatin.
"Our findings show that …
McCormick B. CMS releases preliminary drug list for Medicare $2 drug list model. AJMC®. October 10, …
-
Statins linked to reduced liver cancer risk in major cohort study
20 Mar 2025 19:35 GMT
… in the journal JAMA Internal Medicine.
Hepatocellular carcinoma remains a … through inverse probability of treatment weighting.
Statin use correlated with significantly … reduction observed with hydrophilic statins such as rosuvastatin and pravastatin (aSHR 0 …
-
Pimentel praises VAT-Free drugs, calls for wider coverage
20 Mar 2025 11:30 GMT
… financial burden of Filipinos needing medical treatment.
"Every peso saved … Food and Drug Administration (FDA), the newly VAT-free medicines include treatments for … mental illness.
Among them are rosuvastatin for cholesterol management, sitagliptin + …